Sex-related differences in the rates of asthma onset and remission suggest that sex hormones may play a role in the pathogenic mechanisms that underly some forms of asthma. A study led by researchers at Peking University Third Hospital Cancer Center, Peking University, has now found that in mice, male sex hormones can suppress allergic responses by promoting sympathetic nerve connections and norepinephrine release in the lungs. The findings help to illuminate mechanisms that underlie sex differences in allergic diseases and could help inform future therapeutics to treat type 2 immune inflammatory conditions such as asthma.

Rznomics is joining Lilly Gateway Labs (LGL) in San Diego. The company is a clinical-stage biopharmaceutical firm based in South Korea focused on developing RNA-based gene therapies.